Cargando…
Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
A growing body of literature links events associated with the progression and severity of immunity and inflammatory disease with the composition of the tissue extracellular matrix as defined by the matrisome. One protein in the matrisome that is common to many inflammatory diseases is the large prot...
Autores principales: | Hirani, Priyanka, Gauthier, Valentine, Allen, Carys E., Wight, Thomas N., Pearce, Oliver M. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435723/ https://www.ncbi.nlm.nih.gov/pubmed/34527586 http://dx.doi.org/10.3389/fonc.2021.712807 |
Ejemplares similares
-
Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation
por: Wight, Thomas N., et al.
Publicado: (2020) -
Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
por: Meyers, Daniel E., et al.
Publicado: (2017) -
Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014) -
Immunotherapeutic Potential of T Memory Stem Cells
por: Li, Yujie, et al.
Publicado: (2021) -
Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)